StockNews.com Begins Coverage on CASI Pharmaceuticals (NASDAQ:CASI)
Equities research analysts at StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright lowered their price target on CASI Pharmaceuticals from $6.00 to $4.00 and set […]
Equities research analysts at StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright lowered their price target on CASI Pharmaceuticals from $6.00 to $4.00 and set […]
